We are trying to find patients at the highest risk and treat them for a longer period of time.

However, the effect is moderate, and further studies in younger people and over longer periods of time are needed in order to demonstrate clinical usefulness.

We are the first, and we truly had to work for that. It's quite unusual. People are not given to adventures in our field. We've done it and we are very pleased.

It only shows the feasibility of this approach. It is safe and it can be done, but it is a relatively small study and the time frame on the drug was only two years and generally, in our field, we want to see longer-term studies, so we're not ready to recommend this as a massive way of treating patients.

I'm still trying to figure out how I got the idea, if I did, to revive the original Flash after five or six years.

I'm a high-risk taker on the court in the sense of trying to squeeze things in there, so as a player, yeah,